PropertyValue
?:abstract
  • Transplant recipients may be more susceptible to COVID-19 and itsrelated complications.1-3 Despite most patients being managed with reduction of immunosuppression, the risk of rejection or graft loss does not seem to be increased during COVID-19.
is ?:annotates of
?:creator
?:doi
  • 10.1111/ctr.14149
?:doi
?:journal
  • Clinical_transplantation
?:license
  • unk
?:pmid
?:pmid
  • 33179350
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • Medline
?:title
  • Rabbit anti-thymocyte globulin administration to treat rejection in simultaneous pancreas and kidney transplant recipients with recent COVID-19 infection.
?:type
?:year
  • 2020-11-11

Metadata

Anon_0  
expand all